Outcomes of shoulder replacement in humeral head avascular necrosis

Ristow, Jacob; Ellison, C.M.; Mickschl, Dara J.; Berg, Kenneth C.; Haidet, Kirk C.; Gray, Jason R.; Grindel, Steven I.

doi:10.1016/j.jse.2018.06.031

Cited by 23 publications

(22 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ultimately, six studies were included in this review ( Fig. 1 ): three retrospective cohort studies (2 level III and 1 level IV evidence) 4 , 7 , 25 and three case series (level IV evidence). 10 , 13 , 14 In those six studies, forty-three (SCD) patients, comprising forty-nine shoulders, underwent different surgical interventions for HHAVN ( Table II ).…”

Section: Resultsmentioning

confidence: 99%

“…of shoulders (patients) Mean age (range) No. of shoulders (patients) % of SCD shoulders Ristow et al 25 2019 III Retrospective cohort TSA vs. HA 29 (25) 49 (16-77) 8 (6) 27.6 22 Colegate-Stone et al 4 2018 IV Retrospective cohort Arthroscopic intervention∗, HA, and RTSA 45 (45) 40 (21-62) 11 (11) 24.4 II, III, IV 11 Kennon et al 13 2016 IV Case series Decompression, resurfacing, HA, TSA, and RTSA 25 (20) 37 ± 15 13 (11) 52 I, II, III, IV 14 Harreld et al 10 2009 IV Case series Decompression 26 (15) 37 (15-50) 5 (3) 19.2 I, II 20 Feeley et al 7 2008 III Retrospective cohort TSA vs. HA 64 (64) 57 (46-77) 4 (4) 6.2 22 Lau et al. 14 2007 IV Case series TSA, HA 8 (8) 37 (25-47) 8 (8) 100 II, III, IV, V …”

Section: Resultsmentioning

confidence: 99%

“…Since then, several studies have described the outcomes of surgical treatment in patients with HHAVN of different etiologies. 25 However, these studies are few and have limited patients. In addition, they fail to compare surgical outcomes of different etiologies, with the patients with SCD being notably underrepresented.…”

mentioning

confidence: 99%

“…In addition, they fail to compare surgical outcomes of different etiologies, with the patients with SCD being notably underrepresented. 25 …”

mentioning

confidence: 99%

See 3 more Smart Citations

Surgical treatment of humeral head avascular necrosis in patients with sickle cell disease: a systematic review

et al. 2021

View full text Add to dashboard Cite

Background Sickle cell disease is the leading etiology for atraumatic humeral head avascular necrosis worldwide. Treatment of this condition is not standardized, with only few studies evaluating clinical outcomes after surgical interventions. The aim of this study was to review the available evidence on the results of surgical intervention for humeral head avascular necrosis in the sickle cell disease population. Methods A systematic electronic search was conducted using PubMed (MEDLINE), EMBASE, and Cochrane Library databases. Relevant studies that reported the outcomes of surgical intervention for humeral head avascular necrosis for patients with sickle cell disease were reviewed. Outcome parameters were pain, range of motion, specific shoulder outcome scores, and complications. Results Six studies, three retrospective cohorts (2 level III and 1 level IV) and three case series (level IV), were included in this review. A total of forty-three patients with sickle cell disease, comprising forty-nine shoulders, underwent different surgical procedures. Surgical procedures were core decompression, arthroscopic intervention, humeral head resurfacing, shoulder hemiarthroplasty, and total shoulder arthroplasty. Conclusion Surgical intervention for humeral head avascular necrosis in patients with sickle cell disease is selected based on the osteonecrosis stage. In the precollapse stage, core decompression is regarded as the first surgical option. However, in the light of current evidence, it has not been confirmed to prevent or delay natural progression of the disease. Shoulder arthroplasty is reserved for late stages, which despite the fairly good outcomes, data for long-term implant survival and complications are not well documented.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

mentioning

confidence: 99%

“…In addition, they fail to compare surgical outcomes of different etiologies, with the patients with SCD being notably underrepresented. 25 …”

mentioning

confidence: 99%

See 2 more Smart Citations

Surgical treatment of humeral head avascular necrosis in patients with sickle cell disease: a systematic review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Nevertheless, several concerns about TSA linger, such as limited prosthesis longevity and frustrating glenoid loosening, along with technically demanding revisions, which may cause pain and loss of function [3,[10][11][12][13]. To address these problems, hemiarthroplasty (HA) is introduced as a viable option for the treatment of shoulder disorders [14][15][16][17][18], and is widely applied in various age groups [19][20][21]. It only replaces the humeral side and avoids potential complications associated with glenoid implantation [1,22], as shown by patient-reported outcomes [23][24][25].…”

Section: Introductionmentioning

confidence: 99%

Resurfacing hemiarthroplasty versus stemmed hemiarthroplasty for glenohumeral osteoarthritis: a meta-analysis

et al. 2020

View full text Add to dashboard Cite

Background: Though total shoulder arthroplasty (TSA) has been an acknowledged treatment option for glenohumeral osteoarthritis, resurfacing hemiarthroplasty (RHA) and stemmed hemiarthroplasty (SHA) may be preferred in some circumstances by surgeons, especially for treating young or active patients. However, decision-making between the RHA and SHA is controversial. Therefore, we conducted a meta-analysis to systematically compare two surgical procedures in terms of postoperative functional outcomes, range of motion (ROM), pain relief, complication rates, risk of revision. Methods: The PubMed, Embase, Web of Science and Cochrane Library were searched from inception to January 1, 2020, for all articles that compared the clinical effectiveness and safety of RHA with SHA. All eligible studies were selected based on certain screening criteria. Two investigators independently conducted the quality assessment and extracted the data. Fixed-effect and random-effect models were used for pooled results according to the degree of heterogeneity. All statistical analyses were performed by employing Stata software 14.0. Results: A total of six comparative studies involving 2568 shoulders (1356 RHA and 1212 SHA) were included in the final analysis. Patients were followed up for at least 1 year in each study. Pooled results showed that RHA was associated with a better visual analog scale (SMD 0.61, p = 0.001) but higher revision rates (OR 1.50, p = 0.016) when compared to SHA. There were no significant differences in functional outcomes, such as Constant-Murley score (SMD 0.06, P = 0.878), American Shoulder and Elbow Surgeons score (SMD 0.05, P = 0.880), Western Ontario Osteoarthritis of the Shoulder index (SMD 0.43, p = 0.258) and quick-Disabilities of the Arm, Shoulder and Hand score (SMD 0.06, p = 0.669). In addition, no differences were observed in forward flexion (SMD 0.16, p = 0.622), external rotation (SMD-0.17, P = 0.741) and overall complication rates (OR 1.42, p = 0.198).

show abstract